Anti-inflammatoryand immunomodulatory potential of zetomipzomib (kzr-616) for active systemic lupus erythematosus with orwithout lupus nephritis: results from the open-label mission study
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY（2023）
Key words
Lupus nephritis, Systemic lupus erythematosus, Zetomipzomib
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined